No Clinically Significant Drug-Drug Interaction Between Allopurinol and Valproate
There is no clinically significant drug-drug interaction between allopurinol and valproic acid (valproate), and these medications can be safely co-administered without dose adjustments.
Evidence Base
The FDA drug labels for both medications do not list each other as interacting drugs. The allopurinol label 1 specifically mentions interactions with mercaptopurine, azathioprine, dicumarol, thiazide diuretics, chlorpropamide, and cyclosporine, but makes no mention of valproate. Similarly, the valproate label 2 extensively details drug interactions including aspirin, carbapenem antibiotics, estrogen-containing contraceptives, felbamate, rifampin, amitriptyline, carbamazepine, diazepam, ethosuximide, lamotrigine, and phenobarbital—but does not include allopurinol.
Supporting Research Evidence
Direct experimental evidence confirms the absence of interaction. A preclinical study 3 specifically investigated whether allopurinol affects valproate's anticonvulsant activity in mice. The researchers found that:
- Allopurinol (at doses of 5,15, or 45 mg/kg) did not affect the anticonvulsant efficacy of valproate
- Free plasma concentrations of valproate were unchanged when co-administered with allopurinol
- This held true for both acute and chronic (5-day) allopurinol administration
Additional research 4 examined combined allopurinol and valproic acid treatment in rats, demonstrating that both drugs could be administered together without adverse pharmacokinetic interactions, though this study focused on cardiac effects rather than drug interactions per se.
Clinical Implications
You can prescribe allopurinol and valproate together without:
- Dose adjustments for either medication
- Additional monitoring beyond standard therapeutic drug monitoring for valproate (if clinically indicated)
- Concerns about altered seizure control or uric acid management
Important Caveats
While these two drugs don't interact with each other, remember that:
- Allopurinol requires dose reduction (by 65-75%) when used with azathioprine or mercaptopurine 5, 1
- Valproate has numerous significant interactions with other anticonvulsants, particularly lamotrigine (requiring lamotrigine dose reduction) and phenobarbital 2
- Carbapenem antibiotics dramatically reduce valproate levels and should be avoided in patients on valproate therapy 2, 6